BBIO · Bull vs Bear

The case for and the case against BridgeBio Pharma, Inc., each point drawn from public SEC filings — who’s buying, the red flags, and the health score. No opinion, no price call. Read both sides, then pick yours.

the bull case // 1

Institutions hold it

Held by 1 of the 13F institutional filers we track.

SEC 13F →

the bear case // 3

Bankruptcy-risk zone

Altman Z-Score is in the distress zone (-3.14).

SEC filing ↗

Insiders are selling

9 insider sales recently with no offsetting open-market buys.

SEC Form 4 →

Weak financial strength

Piotroski F 3/9 (8 measured)

SEC XBRL

where do you land on BBIO?

Bull Bear

Saved on this device. Your call, from the evidence above — not a recommendation.

Educational only — not financial adviceand never a recommendation to buy or sell. Both sides are built from public SEC filings (Form 4, STOCK Act, 13F, XBRL financials), which lag 40–90 days; absence of a red flag is not a clean bill of health.